A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia
- PMID: 10408534
- DOI: 10.1212/wnl.53.1.38
A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia
Abstract
Objective: To search for mutations in the calcium channel gene CACNA1A and to study the genotype-phenotype correlation in a family with a severe familial hemiplegic migraine (FHM) phenotype and a slowly progressive cerebellar ataxia.
Background: CACNA1A gene mutations on chromosome 19 are involved in approximately 50% of FHM families. The association of FHM and cerebellar ataxia has been reported in a small number of FHM families, all linked to chromosome 19.
Methods: The proband, in addition to typical hemiplegic migraine attacks, experienced severe episodes during which hemiplegia was associated with acutely altered consciousness and fever lasting several days. She, as well as her affected sister, developed a permanent, late-onset cerebellar ataxia and cerebellar atrophy evident on MRI. Linkage analysis was performed and the whole CACNA1A gene, 47 exon-intron boundaries, was analyzed by double gradient-denaturing gradient gel electrophoresis (DG-DGGE).
Results: Genetic studies suggested linkage to chromosome 19p13, and DG-DGGE analysis detected a heteroduplex fragment in exon 13 of the CACNA1A gene. By direct sequencing, a G-to-A substitution resulting in an arginine to glutamine change at codon 583 in the second putative voltage sensor domain of the channel alpha1A-subunit, was identified, possibly representing the disease-causing mutation. The proband and her affected sister were treated with acetazolamide, reporting freedom from new FHM attacks but no benefit in the progression of ataxia.
Conclusions: The combination of episodic dysfunction and permanent deficit could depend on the variety of functions of calcium channels and their distribution in the nervous system.
Comment in
-
CACNA1A mutations: hemiplegic migraine, episodic ataxia type 2, and the others.Neurology. 1999 Jul 13;53(1):3-4. doi: 10.1212/wnl.53.1.3. Neurology. 1999. PMID: 10408526 Review. No abstract available.
Similar articles
-
Genetic heterogeneity in Italian families with familial hemiplegic migraine.Neurology. 1999 Jul 13;53(1):26-33. doi: 10.1212/wnl.53.1.26. Neurology. 1999. PMID: 10408532
-
Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group.Neurology. 1998 Apr;50(4):1105-10. doi: 10.1212/wnl.50.4.1105. Neurology. 1998. PMID: 9566402
-
Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM.Hum Genet. 1999 Sep;105(3):261-5. doi: 10.1007/s004390051099. Hum Genet. 1999. PMID: 10987655
-
CACNA1A mutations: hemiplegic migraine, episodic ataxia type 2, and the others.Neurology. 1999 Jul 13;53(1):3-4. doi: 10.1212/wnl.53.1.3. Neurology. 1999. PMID: 10408526 Review. No abstract available.
-
Familial hemiplegic migraine: involvement of a calcium neuronal channel.Neurologia. 1997 Dec;12 Suppl 5:31-7. Neurologia. 1997. PMID: 9436352 Review.
Cited by
-
Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies.Mol Genet Genomic Med. 2013 Nov;1(4):206-22. doi: 10.1002/mgg3.24. Epub 2013 Jul 2. Mol Genet Genomic Med. 2013. PMID: 24498617 Free PMC article.
-
The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type (Ca(V)2.1) calcium channels expressed in human embryonic kidney cells.J Physiol. 2003 Jan 15;546(Pt 2):337-47. doi: 10.1113/jphysiol.2002.026716. J Physiol. 2003. PMID: 12527722 Free PMC article.
-
Pathophysiological role of omega pore current in channelopathies.Front Pharmacol. 2012 Jun 11;3:112. doi: 10.3389/fphar.2012.00112. eCollection 2012. Front Pharmacol. 2012. PMID: 22701429 Free PMC article.
-
Episodic ataxia type 1: a neuronal potassium channelopathy.Neurotherapeutics. 2007 Apr;4(2):258-66. doi: 10.1016/j.nurt.2007.01.010. Neurotherapeutics. 2007. PMID: 17395136 Review.
-
Calcium signalling in mammalian cell lines expressing wild type and mutant human α1-Antitrypsin.Sci Rep. 2019 Nov 21;9(1):17293. doi: 10.1038/s41598-019-53535-1. Sci Rep. 2019. PMID: 31754242 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical